Limited data are available on the effects of systemic immunomodulatory treatments on COVID-19 outcomes in patients with atopic dermatitis (AD).
The effects of systemic immunomodulatory treatments on COVID-19 outcomes in patients with atopic dermatitis: results from the global SECURE-AD registry
Patruno, C;
2022-01-01
Abstract
Limited data are available on the effects of systemic immunomodulatory treatments on COVID-19 outcomes in patients with atopic dermatitis (AD).File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
